The Study of Weiweikang Treating Chronic Atrophic Gastritis and Analysis of the Prescription
Teng Jia-lin
Abstract
Teng Jia-lin
Abstract
Objective:To study function of Weiweikang on treating chronic atrophic gastritis(CAG) model rats.Method: Twelve rats were randomly selected from 70 Wistar rats as normal control group(normal group).The remaining 58 rats were made CAG model with the multiple stimulations for 6 weeks.The remaining 50 rats which were modelede successfully were randomly divided into five groups such as model group,Weiweikang whole formula group(the whole formula group),split part Ⅰ group(buyi group),split part Ⅱ group(quxie group)and western medicine control group(western medicine group).The rats in every groups were ig 0.9% saline(0.09 g · kg-1),Weiweikang decoction(8 g · kg-1),split part I decoction(5.5 g · kg-1),split part Ⅱ decoction(2.5 g · kg-1) and the neomycin-dimensional suspension(0.3 g · kg-1),once a day,respectively.After 90 days of treatment,the gastric mucosa pathological changes were observed,the changes of superoxide dismutas(SOD)and malonyl dialdehyd(MDA)content in blood serum were detect.Result: There was no marked difference in the different-iation of gastric mucosa pathematology and microanatomy between the whole formula group and the normal group.Compared with normal control group whose SOD is(239.88±6.32) U·mL-1and MDA is(3.17±0.02) μmol·L-1,SOD of model group with(174.59±12.81) U·mL-1decrease significantly(P0.01) and MDA of model group with(5.14±0.15) μmol·L-1 increase significantly(P0.01).Compared with model group,the other medication groups made a significant increase of SOD and made the level of MDA decrease significantly(P0.01 or P0.05);Compared with model group with SOD(174.59±12.81) U·mL-1,MDA(5.14±0.15) μmol·L-1,the other medication groups made a significant increase of SOD and the level of MDA decrease significantly(P0.01 or P0.05);Compared with the whole formula group with SOD(233.91±9.03) U·mL-1,MDA:(3.11±0.19) μmol·L-1,the buyi group and quxie group made a significant decrease of SOD and made the level of MDA increase significantly(P0.01 or P0.05);Compared with the buyi group with SOD(221.58±5.71) U·mL-1,the activity of SOD with(209.89±5.27) U·mL-1 in serum was significantly lower in quxie group rats(P0.05).Conclusion: Weiweikang can improve and reverse the gastric atrophy of experimental atrophic gastritis of rats,among which ingredinets with benefiting QI and nourishing YIN founctios play a major role and ingredients with expelling pathogen plays synergy action.Its mechanism may be related to scavenging resisting the free radicals.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study function of Weiweikang on treating chronic atrophic gastritis(CAG) model rats.Method: Twelve rats were randomly selected from 70 Wistar rats as normal control group(normal group).The remaining 58 rats were made CAG model with the multiple stimulations for 6 weeks.The remaining 50 rats which were modelede successfully were randomly divided into five groups such as model group,Weiweikang whole formula group(the whole formula group),split part Ⅰ group(buyi group),split part Ⅱ group(quxie group)and western medicine control group(western medicine group).The rats in every groups were ig 0.9% saline(0.09 g · kg-1),Weiweikang decoction(8 g · kg-1),split part I decoction(5.5 g · kg-1),split part Ⅱ decoction(2.5 g · kg-1) and the neomycin-dimensional suspension(0.3 g · kg-1),once a day,respectively.After 90 days of treatment,the gastric mucosa pathological changes were observed,the changes of superoxide dismutas(SOD)and malonyl dialdehyd(MDA)content in blood serum were detect.Result: There was no marked difference in the different-iation of gastric mucosa pathematology and microanatomy between the whole formula group and the normal group.Compared with normal control group whose SOD is(239.88±6.32) U·mL-1and MDA is(3.17±0.02) μmol·L-1,SOD of model group with(174.59±12.81) U·mL-1decrease significantly(P0.01) and MDA of model group with(5.14±0.15) μmol·L-1 increase significantly(P0.01).Compared with model group,the other medication groups made a significant increase of SOD and made the level of MDA decrease significantly(P0.01 or P0.05);Compared with model group with SOD(174.59±12.81) U·mL-1,MDA(5.14±0.15) μmol·L-1,the other medication groups made a significant increase of SOD and the level of MDA decrease significantly(P0.01 or P0.05);Compared with the whole formula group with SOD(233.91±9.03) U·mL-1,MDA:(3.11±0.19) μmol·L-1,the buyi group and quxie group made a significant decrease of SOD and made the level of MDA increase significantly(P0.01 or P0.05);Compared with the buyi group with SOD(221.58±5.71) U·mL-1,the activity of SOD with(209.89±5.27) U·mL-1 in serum was significantly lower in quxie group rats(P0.05).Conclusion: Weiweikang can improve and reverse the gastric atrophy of experimental atrophic gastritis of rats,among which ingredinets with benefiting QI and nourishing YIN founctios play a major role and ingredients with expelling pathogen plays synergy action.Its mechanism may be related to scavenging resisting the free radicals.
Key concepts: Decoction, Atrophic gastritis, Saline, Medicine, Gastroenterology, Internal medicine, Gastric mucosa, Superoxide dismutase